ROCK1 and glioblastoma: Since we observed a significant benefit from reducing ROCK1 levels both in human cells in culture and in intact C. elegans aggregation models, we measured its levels in T98G glioblastoma cells that overexpress either the APOE3 or APOE4 allele.